School of Medicine

The risk of developing long COVID has decreased significantly over the course of the COVID-19 pandemic, primarily due to vaccination, according to a new analysis led by School of Medicine researchers.

A School of Medicine brain-imaging study on the effects of psilocybin, the active compound in magic mushrooms, provides a neurobiological explanation for the drug’s mind-bending effects.

Research from Washington University School of Medicine in St. Louis reveals how brain inflammation triggers extreme muscle weakness across several diseases, including viral infection, bacterial infection and Alzheimer’s disease.

Juliane Bubeck Wardenburg, MD, PhD, and Russell Pachynski, MD, both of Washington University School of Medicine in St. Louis, have been honored with the 2024 Scholar-Innovator Award from the Harrington Discovery Institute at University Hospitals in Cleveland.

Washington University School of Medicine in St. Louis faculty members David M. Holtzman, MD, and Xiaoying Chen were awarded the inaugural Jeffrey L. Morby Prize from the Cure Alzheimer’s Fund.

Racial disparities in dementia are due to social determinants of health, with genetic ancestry playing no role, according to a new study led by researchers at Washington University School of Medicine in St. Louis.

Christina Gurnett, MD, PhD, and Fred Ssewamala, PhD, have been chosen by their academic peers to receive Washington University in St. Louis’ 2024 faculty achievement awards, Chancellor Andrew D. Martin announced.

Researchers at the School of Medicine have identified a novel enzyme involved in building the cell wall of Cryptococcus neoformans, a fungus that causes lung infections and potentially deadly cases of meningitis, primarily in people with AIDS.

Researchers at Washington University have found some potential biological clues to explain how prenatal cannabis exposure leads to behavioral issues down the line.

Researchers at Washington University School of Medicine in St. Louis, with collaborators at the University of Florida and Stanford University, identified a compound that, in mice, makes naloxone much more effective at counteracting a drug overdose.